Neurological Sciences

, Volume 32, Issue 1, pp 41–51 | Cite as

The effect of lentivirus-mediated TH and GDNF genetic engineering mesenchymal stem cells on Parkinson’s disease rat model

Original Article


This study was designed to assess the potential therapeutic efficacy of gene-modified mesenchymal stem cells (MSCs), MSCs-TH and MSCs-GDNF, in PD rats. Fifty-nine PD rat models were divided into five groups and then the gene-modified MSCs were transplanted into the striatum of rats according to the design. Apomorphine-induced rotational behavior in rats was observed weekly; rats which received both MSCs-TH and MSCs-GDNF showed the most significant improvement compared with those in other groups (P < 0.01). Three weeks later, immunohistochemistry analysis found TH-positive cells and GDNF-positive cells in striatal. Eight weeks later, PD rats were killed. HPLC and ELISA results showed DA and GDNF content in striatum of rats which received both MSCs-TH, and MSCs-GDNF was considerably higher compared with those of other groups (P < 0.01),respectively. In conclusion, our results suggest that combined transplantation of MSCs expressing TH and GDNF can lead to remarkable therapeutic effects in a rat model of PD.


Mesenchymal stem cells TH gene GDNF gene Parkinson’s disease Gene transfection 


  1. 1.
    Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rub U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol 249(Suppl 3):III/1–5Google Scholar
  2. 2.
    Lotharius J, Brundin P (2002) Pathogenesis of Parkinson’s disease: dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci 3:932–942CrossRefPubMedGoogle Scholar
  3. 3.
    Gerlach M, Braak H, Hartmann A, Jost WH, Odin P, Priller J, Schwarz J (2002) Current state of stem cell research for the treatment of Parkinson’s disease. J Neurol 249(Suppl 3):III/33–35Google Scholar
  4. 4.
    Bensadoun JC, Deglon N, Tseng JL, Ridet JL, Zurn AD, Aebischer P (2000) Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson’s disease using GDNF. Exp Neurol 164:15–24CrossRefPubMedGoogle Scholar
  5. 5.
    Choi-Lundberg DL, Lin Q, Chang YN, Chiang YL, Hay CM, Mohajeri H, Davidson BL, Bohn MC (1997) Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275:838–841CrossRefPubMedGoogle Scholar
  6. 6.
    Kirik D, Rosenblad C, Bjorklund A, Mandel RJ (2000) Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson’s model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system. J Neurosci 20:4686–4700PubMedGoogle Scholar
  7. 7.
    Kordower JH, Emborg ME, Bloch J, Ma SY, Chu Y, Leventhal L, McBride J, Chen EY, Palfi S, Roitberg BZ, Brown WD, Holden JE, Pyzalski R, Taylor MD, Carvey P, Ling Z, Trono D, Hantraye P, Deglon N, Aebischer P (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson’s disease. Science 290:767–773CrossRefPubMedGoogle Scholar
  8. 8.
    Mandel RJ, Snyder RO, Leff SE (1999) Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson’s disease. Exp Neurol 160:205–214CrossRefPubMedGoogle Scholar
  9. 9.
    Mandel RJ, Spratt SK, Snyder RO, Leff SE (1997) Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson’s disease in rats. Proc Natl Acad Sci USA 94:14083–14088CrossRefPubMedGoogle Scholar
  10. 10.
    Barker RA (2000) Prospects for the treatment of Parkinson’s disease using neural grafts. Expert Opin Pharmacother 1:889–902CrossRefPubMedGoogle Scholar
  11. 11.
    Kordower JH, Freeman TB, Chen EY, Mufson EJ, Sanberg PR, Hauser RA, Snow B, Olanow CW (1998) Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson’s disease. Mov Disord 13:383–393CrossRefPubMedGoogle Scholar
  12. 12.
    Olanow CW, Freeman T, Kordower J (2001) Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. N Engl J Med 345:146 author reply 147CrossRefPubMedGoogle Scholar
  13. 13.
    Woodbury D, Schwarz EJ, Prockop DJ, Black IB (2000) Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61:364–370CrossRefPubMedGoogle Scholar
  14. 14.
    Brazelton TR, Rossi FM, Keshet GI, Blau HM (2000) From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290:1775–1779CrossRefPubMedGoogle Scholar
  15. 15.
    Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR (2000) Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290:1779–1782CrossRefPubMedGoogle Scholar
  16. 16.
    Munoz-Elias G, Marcus AJ, Coyne TM, Woodbury D, Black IB (2004) Adult bone marrow stromal cells in the embryonic brain: engraftment, migration, differentiation, and long-term survival. J Neurosci 24:4585–4595CrossRefPubMedGoogle Scholar
  17. 17.
    Woodbury D, Reynolds K, Black IB (2002) Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis. J Neurosci Res 69:908–917CrossRefPubMedGoogle Scholar
  18. 18.
    Moffat M, Harmon S, Haycock J, O’Malley KL (1997) L-Dopa and dopamine-producing gene cassettes for gene therapy approaches to Parkinson’s disease. Exp Neurol 144:69–73CrossRefPubMedGoogle Scholar
  19. 19.
    Jiang Q, Liu J, Ge K, Liu WC, Sun LY, Liu XY, Zheng ZC (1999) Cloning of glial cell line-derived neurotrophic factor gene and its expression in eukaryotic cells. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 31:150–154Google Scholar
  20. 20.
    Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263–267CrossRefPubMedGoogle Scholar
  21. 21.
    Qin D, Zeng Y, Qian C, Huang Z, Lv Z, Cheng L, Yao S, Tang Q, Chen X, Lu C (2008) Induction of lytic cycle replication of Kaposi’s sarcoma-associated herpesvirus by herpes simplex virus type 1: involvement of IL-10 and IL-4. Cell Microbiol 10:713–728CrossRefPubMedGoogle Scholar
  22. 22.
    Hudson JL, van Horne CG, Stromberg I, Brock S, Clayton J, Masserano J, Hoffer BJ, Gerhardt GA (1993) Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res 626:167–174CrossRefPubMedGoogle Scholar
  23. 23.
    Olanow CW, Brin MF, Obeso JA (2000) The role of deep brain stimulation as a surgical treatment for Parkinson’s disease. Neurology 55:S60–S66PubMedGoogle Scholar
  24. 24.
    Krause M, Fogel W, Heck A, Hacke W, Bonsanto M, Trenkwalder C, Tronnier V (2001) Deep brain stimulation for the treatment of Parkinson’s disease: subthalamic nucleus versus globus pallidus internus. J Neurol Neurosurg Psychiatry 70:464–470CrossRefPubMedGoogle Scholar
  25. 25.
    Bjorklund A, Kirik D, Rosenblad C, Georgievska B, Lundberg C, Mandel RJ (2000) Towards a neuroprotective gene therapy for Parkinson’s disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model. Brain Res 886:82–98CrossRefPubMedGoogle Scholar
  26. 26.
    Shingo T, Date I, Yoshida H, Ohmoto T (2002) Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson’s disease. J Neurosci Res 69:946–954CrossRefPubMedGoogle Scholar
  27. 27.
    Wang ZH, Ji Y, Shan W, Zeng B, Raksadawan N, Pastores GM, Wisniewski T, Kolodny EH (2002) Therapeutic effects of astrocytes expressing both tyrosine hydroxylase and brain-derived neurotrophic factor on a rat model of Parkinson’s disease. Neuroscience 113:629–640CrossRefPubMedGoogle Scholar
  28. 28.
    Gallichan WS, Kafri T, Krahl T, Verma IM, Sarvetnick N (1998) Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. Hum Gene Ther 9:2717–2726CrossRefPubMedGoogle Scholar
  29. 29.
    Ju Q, Edelstein D, Brendel MD, Brandhorst D, Brandhorst H, Bretzel RG, Brownlee M (1998) Transduction of non-dividing adult human pancreatic beta cells by an integrating lentiviral vector. Diabetologia 41:736–739CrossRefPubMedGoogle Scholar
  30. 30.
    Kafri T, Blomer U, Peterson DA, Gage FH, Verma IM (1997) Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 17:314–317CrossRefPubMedGoogle Scholar
  31. 31.
    Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM (1998) Development of a self-inactivating lentivirus vector. J Virol 72:8150–8157PubMedGoogle Scholar
  32. 32.
    Rebolledo MA, Krogstad P, Chen F, Shannon KM, Klitzner TS (1998) Infection of human fetal cardiac myocytes by a human immunodeficiency virus-1-derived vector. Circ Res 83:738–742PubMedGoogle Scholar
  33. 33.
    Sutton RE, Wu HT, Rigg R, Bohnlein E, Brown PO (1998) Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells. J Virol 72:5781–5788PubMedGoogle Scholar
  34. 34.
    Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L (1998) A third-generation lentivirus vector with a conditional packaging system. J Virol 72:8463–8471PubMedGoogle Scholar
  35. 35.
    Van Damme A, Thorrez L, Ma L, Vandenburgh H, Eyckmans J, Dell’Accio F, De Bari C, Luyten F, Lillicrap D, Collen D, VandenDriessche T, Chuah MK (2006) Efficient lentiviral transduction and improved engraftment of human bone marrow mesenchymal cells. Stem Cells 24:896–907CrossRefPubMedGoogle Scholar
  36. 36.
    Azizi SA, Stokes D, Augelli BJ, DiGirolamo C, Prockop DJ (1998) Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats–similarities to astrocyte grafts. Proc Natl Acad Sci USA 95:3908–3913CrossRefPubMedGoogle Scholar
  37. 37.
    Mezey E, Key S, Vogelsang G, Szalayova I, Lange GD, Crain B (2003) Transplanted bone marrow generates new neurons in human brains. Proc Natl Acad Sci USA 100:1364–1369CrossRefPubMedGoogle Scholar
  38. 38.
    Eglitis MA, Mezey E (1997) Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci USA 94:4080–4085CrossRefPubMedGoogle Scholar
  39. 39.
    Crigler L, Robey RC, Asawachaicharn A, Gaupp D, Phinney DG (2006) Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol 198:54–64CrossRefPubMedGoogle Scholar
  40. 40.
    Garcia R, Aguiar J, Alberti E, de la Cuetara K, Pavon N (2004) Bone marrow stromal cells produce nerve growth factor and glial cell line-derived neurotrophic factors. Biochem Biophys Res Commun 316:753–754CrossRefPubMedGoogle Scholar
  41. 41.
    Mahmood A, Lu D, Chopp M (2004) Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. J Neurotrauma 21:33–39CrossRefPubMedGoogle Scholar
  42. 42.
    During MJ, Naegele JR, O’Malley KL, Geller AI (1994) Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266:1399–1403CrossRefPubMedGoogle Scholar
  43. 43.
    Pereira RF, Halford KW, O’Hara MD, Leeper DB, Sokolov BP, Pollard MD, Bagasra O, Prockop DJ (1995) Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci USA 92:4857–4861CrossRefPubMedGoogle Scholar
  44. 44.
    Weimann JM, Charlton CA, Brazelton TR, Hackman RC, Blau HM (2003) Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains. Proc Natl Acad Sci USA 100:2088–2093CrossRefPubMedGoogle Scholar
  45. 45.
    Zhao LR, Duan WM, Reyes M, Keene CD, Verfaillie CM, Low WC (2002) Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol 174:11–20CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Department of NeurosurgeryJiangsu Provincial Hospital of Traditional Chinese MedicineNanjingPeople’s Republic of China
  2. 2.Department of NeurosurgeryThe First Affiliated Hospital of Nanjing Medical UniversityNanjingPeople’s Republic of China
  3. 3.Department of SurgeryThe First Affiliated Hospital of Nanjing Medical UniversityNanjingPeople’s Republic of China

Personalised recommendations